Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pain 2Breast Neoplasms 2Stomach Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Pain, Postoperative 1Neuroma 1Lower Urinary Tract Symptoms 1Low Anterior Resection Syndrome 1Hereditary leiomyomatosis and renal cell cancer 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Chronic Pain 1Carcinoma, Renal Cell 1Agnosia 1

Interventions

Erlotinib Hydrochloride 2Bevacizumab 2pamiparib 1atezolizumab 1Temozolomide 1Specimen Handling 1Magnetic Resonance Spectroscopy 1Immunoglobulin G 1Disulfides 1Contrast Media 1Botulinum Toxins, Type A 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Hereditary leiomyomatosis and renal cell cancer × Botulinum Toxins, Type A × Clear all
NCT00971620 2017-04-07

Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
18 enrolled 22 charts
Genitourinary

Hereditary leiomyomatosis and renal cell cancer, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡